A TCR-based Chimeric Antigen Receptor
Abstract Effector T cells equipped with engineered antigen receptors specific for cancer targets have proven to be very efficient. Two methods have emerged: the Chimeric Antigen Receptors (CARs) and T-cell Receptor (TCR) redirection. Although very potent, CAR recognition is limited to membrane antig...
Guardado en:
Autores principales: | Even Walseng, Hakan Köksal, Ibrahim M. Sektioglu, Anne Fåne, Gjertrud Skorstad, Gunnar Kvalheim, Gustav Gaudernack, Else Marit Inderberg, Sébastien Wälchli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e8a6236e1d04796a5c036d02bcd1d20 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chimeric antigen receptor modified T-cells for cancer treatment
por: Xiao Han, et al.
Publicado: (2018) -
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Chungyong Han, et al.
Publicado: (2018) -
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Nan Li, et al.
Publicado: (2021) -
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Michael S. Hwang, et al.
Publicado: (2021) -
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
por: Nia Emami-Shahri, et al.
Publicado: (2018)